Skip to main content
Journal of Translational Medicine logoLink to Journal of Translational Medicine
. 2024 Sep 11;22:836. doi: 10.1186/s12967-024-05514-y

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

Riley M Larkin 1,2, Diana C Lopez 1,3, Yvette L Robbins 4, Wiem Lassoued 5, Kenneth Canubas 5, Andrew Warner 6, Baktiar Karim 6, Ksenia Vulikh 6, James W Hodge 5, Charalampos S Floudas 5, James L Gulley 5, Gary L Gallia 3,7, Clint T Allen 4, Nyall R London Jr 1,3,7,
PMCID: PMC11391589  PMID: 39261932

Correction to: Journal of Translational Medicine (2022)22:524

10.1186/s12967-024-05339-9

Following publication of the original article [1], we have been notified that there was a mistake in Copyright line.

It is now as follows: © The Author(s) 2024. Open Access. It should be as follows: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024.

The original article was updated.

Footnotes

The online version of the original article can be found at 10.1186/s12967-024-05339-9.

The original version of this article was revised: It is now as follows: © The Author(s) 2024. Open Access. It should be as follows: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Larkin et al. Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses. 2024;22:524 10.1186/s12967-024-05339-9. [DOI] [PMC free article] [PubMed]

Articles from Journal of Translational Medicine are provided here courtesy of BMC

RESOURCES